Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
iRhythm
iRhythmiRhythm Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about iRhythm match what happens in practice?
Public evidence
M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform
HIT Consultant
Public evidence
Sensor-Based Monitoring of Knee Osteoarthritis Symptoms in Free-Living Settings: Scoping Review
JMIR Medical Informatics
Public evidence
Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation
ClinicalTrials.gov AI
Public evidence
Scaling Wireless Continuous Vital Sign Monitoring Across an 8-Hospital Health System: Digital Health Implementation Report
SignalHunt:deployment:response
Public evidence
Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study
JMIR Medical Informatics
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 9 public external signal(s) across 5 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands iRhythm through regulatory records, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand iRhythm. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
The Zio system is a wearable patch that records continuous ECG data for up to 14 days. Proprietary software analyzes this data to generate diagnostic reports for clinicians.According to iRhythm
What iRhythm states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The Zio platform uses deep learning algorithms to analyze recorded cardiac data.
According to iRhythm
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform
According to HIT Consultant
How widely is this actually used?
Reported deployment
Sensor-Based Monitoring of Knee Osteoarthritis Symptoms in Free-Living Settings: Scoping Review
According to JMIR Medical Informatics
How widely is this actually used?
Reported deployment
Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation
According to ClinicalTrials.gov AI
How widely is this actually used?
Reported deployment
Scaling Wireless Continuous Vital Sign Monitoring Across an 8-Hospital Health System: Digital Health Implementation Report
Reported publicly
How widely is this actually used?
Reported outcome
Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study
According to JMIR Medical Informatics
Are you seeing this result?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Product Overview: iRhythm Technologies provides Zio ECG monitors, wearable devices designed for continuous cardiac monitoring, enabling the detection and analysis of arrhythmias over extended periods. • Technical Functionality: The Zio system comprises a comfortable, easy-to-wear patch that records…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings, US, UK, Japan, Austria, Netherlands, Spain
Key strength
Regulatory: FDA 510(k) cleared, CE Mark Class IIa, UKCA marked, Japan Medical Device Approval
Key capabilities
Continuous 14-day ECG monitoring, Wireless data transmission to ZEUS platform, AI-driven arrhythmia detection
Clinical use cases
Detection of atrial fibrillation in primary care settings, Monitoring of post-operative cardiac patients, Long-term arrhythmia surveillance in cardiology clinics
Who uses it
Cardiologists, Primary care physicians, Electrophysiologists
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of iRhythm accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Across the category
iRhythm against the rest of Imaging & Diagnostics
Category intelligence reads this as Established. A sample of peers, not a census of the category.
Where iRhythm may differ
Differences in what we have recorded. Never a ranking, never a quality judgement.
No first-hand account has been recorded for iRhythm or for any peer we sampled in this category.
A gap across the whole category, not a fact about this technology.
Two readings that disagree
- Category intelligence reads clinical reality here as "Expanding", yet no first-hand account appears in the systems we sampled. Both readings are shown rather than reconciled.
Used another system in Imaging & Diagnostics? How does your experience compare?
A comparison across two systems tests the category, not just one product.
Connected intelligence
Category intelligence